David Peltier


David Peltier joined TheStreet as a research associate in August 2001, and writes TheStreet Stocks Under $10. Before that, Peltier was an analyst for Individual Investor magazine and the publication's Web site. His market interests include small-caps, technology and retail stocks. He has appeared on NPR, NBR and WNYW-TV.

Peltier received his bachelor's degree cum laude in finance and international business from New York University.




A Note From David: My name is David Peltier. I manage a much-followed portfolio for TheStreet called Stocks Under $10 -- the unique investment service that alerts you to what I believe are deeply undervalued stocks with tremendous growth potential.


I've made it my life's work to help investors like you build lasting wealth by investing in only the very best small company stocks.


Because it's these little-known companies, which are overlooked by much of Wall Street, that could break out and double or even triple your money!


Start Your 14-Day Free Trial of Stocks Under $10.


Recent Articles By The Author

Stocks Under $10 Weekly Summary

We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.

GE Raises Its Dividend

Earnings growth expected due to focus on core industrial business.

3 Payout Hikes and a Cut

Bristol-Myers Squibb and Coty are among the companies raising their dividends, as we also highlight coming must-own dates.

Adding to TherapeuticsMD on Weakness

TXMD reported positive clinical data earlier this week.

The Calm Before Dividend-Stock Storm

Prospect of higher interest rates could reappear next week.